Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CHUGAI-PHARMACEUTICAL-CO--6491165/news/Chugai-Pharmaceutical-EMA-und-FDA-nehmen-Zulassungsantrage-fur-Satralizumab-gegen-Neuromyelitis-29487593/?utm_source=whatsapp&utm_medium=social&utm_campaign=share